Reports for HOFFMANN-LA ROCHE LIMITED

Company Name

HOFFMANN-LA ROCHE LIMITED

Totals

Shortage reports

10

Actual shortage: 0 (0%)
Anticipated shortage: 5 (50%)
Avoided shortage: 1 (10%)
Resolved: 4 (40%)

Discontinuation Reports

6

To be discontinued: 1 (17%)
Discontinued: 5 (83%)
Reversed: 0 (0%)

Late reports

1 (6%)

Overdue reports

1 (17%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACTEMRA 80MG SOLUTION Anticipated shortage 2021-08-20 2021-09-08 144365
ACTEMRA 200MG SOLUTION Anticipated shortage 2021-08-23 2021-09-08 144437
ACTEMRA 400MG SOLUTION Anticipated shortage 2021-08-23 2021-09-08 144440
ACTEMRA 162MG SOLUTION Anticipated shortage 2021-07-13 2021-09-08 142457
ACTEMRA 162MG SOLUTION Anticipated shortage 2021-07-12 2021-10-19 142322
ESBRIET 267MG TABLET Resolved 2021-04-20 2021-06-01 137715
RIVOTRIL 0.5TAB 0.5MG TABLET Resolved 2017-11-07 2017-12-13 28573
RIVOTRIL 0.5TAB 0.5MG TABLET Resolved 2018-01-03 2018-04-21 34871
TAMIFLU 6MG POWDER FOR SUSPENSION Avoided shortage 2018-02-08 2018-02-28 39146
TAMIFLU 6MG POWDER FOR SUSPENSION Resolved 2020-02-13 2020-04-21 105912
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
INVIRASE 500MG TABLET Discontinued 2021-01-20 2021-01-20 132101
INVIRASE - CAP 200MG 200MG CAPSULE To be discontinued 2018-06-28 2018-06-28 53093
LECTOPAM TAB 3MG 3MG TABLET Discontinued 2017-08-29 2018-04-03 20572
LECTOPAM TAB 6MG 6MG TABLET Discontinued 2017-08-28 2018-04-03 20448
NUTROPIN AQ PEN CARTRIDGE 10MG SOLUTION Discontinued 2017-06-30 2018-01-04 14451
PEGASYS 180MCG SOLUTION Discontinued 2017-06-30 2018-01-04 14456